Teva Pharmaceutical Finance Vi, LLC

CIK 1536702 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Teva Pharmaceutical Finance Vi, LLC.

Recent SEC filings

FiledFormAccession number
Feb 7, 2025S-3ASR0001193125-25-022747
Oct 27, 2021S-3ASR0001193125-21-308706
Mar 28, 2018S-3/A0001193125-18-099579
Feb 16, 2018S-3/A0001193125-18-048694
Jan 29, 2018S-30001193125-18-023821
Jul 13, 2016POSASR0001193125-16-646966
Feb 9, 2015F-3ASR0001193125-15-039213
Dec 9, 2011F-3ASR0001193125-11-336445